Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.7%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+28.7%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$31.7B
AUM Growth
+$976M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
683
New
Increased
Reduced
Closed

Top Buys

1
+$353M
2
+$325M
3
+$320M
4
TMO icon
Thermo Fisher Scientific
TMO
+$196M
5
USB icon
US Bancorp
USB
+$141M

Top Sells

1
+$128M
2
+$120M
3
+$101M
4
GSK icon
GSK
GSK
+$73.7M
5
DGX icon
Quest Diagnostics
DGX
+$43.1M

Sector Composition

1 Technology 29.69%
2 Healthcare 26%
3 Financials 11.57%
4 Communication Services 9.28%
5 Consumer Discretionary 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
626
– –
-1,452
627
– –
-2,632
628
– –
-3,278
629
– –
-412,722
630
– –
-5,241
631
– –
-42,784
632
– –
-2,684
633
– –
-355,500
634
– –
-275,937
635
– –
-21,300
636
– –
-5,252
637
– –
-227,181
638
– –
-43,272
639
– –
-27,913
640
– –
-13,251
641
– –
-10,310
642
– –
-566,121
643
– –
-2,498
644
– –
-151,153
645
– –
-980
646
– –
-66,583
647
– –
-9,716
648
– –
-7,648
649
– –
-11,404
650
– –
-3,254
24 25
26
27 28